The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTempleton Emerging Markets Regulatory News (TEM)

Share Price Information for Templeton Emerging Markets (TEM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 159.60
Bid: 159.60
Ask: 159.80
Change: 0.20 (0.13%)
Spread: 0.20 (0.125%)
Open: 158.60
High: 160.40
Low: 158.60
Prev. Close: 159.40
TEM Live PriceLast checked at -
Templeton Emerging Markets is an Investment Trust

To provide long-term capital appreciation for private and institutional investors seeking exposure to global emerging markets, supported by both strong customer service and corporate governance.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

6 Oct 2023 08:23

RNS Number : 9725O
Templeton Emerging Markets IT PLC
06 October 2023
 

Templeton Emerging Markets Investment Trust PLC

 

Legal Entity Identifier: 5493002NMTB70RZBXO96

 

Board Appointment

 

 

Templeton Emerging Markets Investment Trust PLC (the "Company") announces that the Board of Directors have agreed to appoint Angus Macpherson as a non-executive Director of the Company, with effect from 6 October 2023. The Board of Directors confirms that the intention is that Angus will take on the role of Chairman of the Company on 1 January 2024 and will work closely with the current Chairman Paul Manduca, who is retiring after over 8 years on the Board, to ensure an orderly handover of the role.

 

Angus Macpherson is chief executive of Noble and Company (UK) Limited, an independent boutique Scottish corporate finance business. He was based in Asia between 1995 and 2004 in Singapore and Hong Kong, latterly as head of capital markets and financing for Merrill Lynch for Asia. He is currently Chairman of Pacific Horizon Investment Trust, Henderson Diversified Income and a director of Schroder Japan Trust and Hampden & Co.

 

Angus Macpherson commented "I am excited to be joining the Board of Templeton Emerging Markets Investment Trust and look forward to working with the other members of the Board and the manager. I have a particular affection for the Company which was a trailblazer in investing in higher growth economies when I first started working in Asia. Paul Manduca has made an outstanding contribution during his tenure as Chairman which, with the help of the Board, I hope to build on."

 

Paul Manduca said "I am delighted that Angus has agreed to join the Board in October and succeed me as Chairman on 1 January 2024. He is a first-class choice to be the next Chairman and I wish both him and the Company the very best for the future." 

 

The Company discloses this information pursuant to Listing Rule 9.6.11.R and 9.6.13 R made by the UK Listing Authority. This disclosure is based upon information provided by this Director and has not been independently verified by the Company.

 

Angus Macpherson has no details to disclose pursuant to Listing Rule 9.6.13 R (2) to Listing Rule 9.6.13 R (6).  He has advised the Board of Pacific Horizon that he intends to step down as Chair as soon as a suitable successor can be appointed.

 

 

For further information please e-mail temitcosec@franklintempleton.com or contact Franklin Templeton Client Dealer Services via e-mail at enquiries@franklintempleton.co.uk  or via free phone 0800 305 306, +44 (0) 20 7073 8690 for overseas investors.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMZMGGNVNGFZG
Date   Source Headline
3rd May 20248:45 amRNSNet Asset Value(s)
2nd May 20249:28 amRNSNet Asset Value(s)
1st May 202410:18 amRNSNet Asset Value(s)
1st May 20249:37 amRNSTotal Voting Rights
30th Apr 20249:05 amRNSNet Asset Value(s)
29th Apr 20244:57 pmRNSTransaction in Own Shares
29th Apr 202410:11 amRNSNet Asset Value(s)
26th Apr 20244:59 pmRNSTransaction in Own Shares
26th Apr 20248:38 amRNSNet Asset Value(s)
25th Apr 20248:52 amRNSNet Asset Value(s)
24th Apr 20244:58 pmRNSTransaction in Own Shares
24th Apr 20248:40 amRNSNet Asset Value(s)
23rd Apr 20244:58 pmRNSTransaction in Own Shares
23rd Apr 20249:27 amRNSNet Asset Value(s)
22nd Apr 20245:02 pmRNSTransaction in Own Shares
22nd Apr 202410:08 amRNSPortfolio Update
22nd Apr 20248:46 amRNSNet Asset Value(s)
19th Apr 20244:57 pmRNSTransaction in Own Shares
19th Apr 20248:48 amRNSNet Asset Value(s)
18th Apr 20244:46 pmRNSTransaction in Own Shares
18th Apr 20248:55 amRNSNet Asset Value(s)
17th Apr 20244:52 pmRNSTransaction in Own Shares
17th Apr 20249:03 amRNSNet Asset Value(s)
16th Apr 20245:05 pmRNSTransaction in Own Shares
16th Apr 20248:36 amRNSNet Asset Value(s)
15th Apr 20244:54 pmRNSTransaction in Own Shares
15th Apr 20249:00 amRNSNet Asset Value(s)
12th Apr 20244:51 pmRNSTransaction in Own Shares
12th Apr 20249:06 amRNSNet Asset Value(s)
11th Apr 20244:54 pmRNSTransaction in Own Shares
11th Apr 20248:43 amRNSNet Asset Value(s)
10th Apr 20244:53 pmRNSTransaction in Own Shares
10th Apr 20248:52 amRNSNet Asset Value(s)
9th Apr 20245:02 pmRNSTransaction in Own Shares
9th Apr 20248:52 amRNSNet Asset Value(s)
8th Apr 20244:53 pmRNSTransaction in Own Shares
8th Apr 20248:49 amRNSNet Asset Value(s)
5th Apr 20248:46 amRNSNet Asset Value(s)
4th Apr 20248:43 amRNSNet Asset Value(s)
3rd Apr 20244:13 pmRNSHolding(s) in Company
3rd Apr 20249:15 amRNSNet Asset Value(s)
2nd Apr 20245:00 pmRNSTransaction in Own Shares
2nd Apr 202410:40 amRNSNet Asset Value(s)
2nd Apr 20249:16 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSNet Asset Value(s)
28th Mar 20249:11 amRNSNet Asset Value(s)
27th Mar 20245:01 pmRNSTransaction in Own Shares
27th Mar 20249:04 amRNSNet Asset Value(s)
26th Mar 20245:03 pmRNSTransaction in Own Shares
26th Mar 20249:10 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.